Literature DB >> 19393030

Mild reduction in the activity of the alpha-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis.

Qingli Shi1, Øystein Risa, Ursula Sonnewald, Gary E Gibson.   

Abstract

Diminished energy metabolism and reduced activity of brain alpha-ketoglutarate dehydrogenase complex (KGDHC) occur in a number of neurodegenerative diseases. The relation between diminished KGDHC activity and altered energy metabolism is unknown. The present study tested whether a reduction in the KGDHC activity would alter cellular metabolism by comparing metabolism of [U-13C]glucose in a human embryonic kidney cell line (E2k100) to one in which the KGDHC activity was about 70% of control (E2k67). After a 2 h incubation of the cells with [U-13C]glucose, the E2k67 cells showed a greater increase in 13C labeling of alanine compared with the E2k100 cells. This suggested an increase in glycolysis. Furthermore, an increase in labeled lactate after 12 h incubation supported the suggestion of an increased glycolysis in the E2k67 cells. Increased GABA shunt in the E2k67 cells was indicated by increased 13C labeling of GABA at both 2 and 12 h compared with the control cells. GABA concentration as determined by HPLC was also increased in the E2k67 cells compared with the control cells. However, the GABA shunt was not sufficient to normalize metabolism in the E2k67 cells compared with control at 2 or 12 h. However, by 24 h metabolism had normalized (i.e. labeling was similar in E2k67 and E2k100). Thus, the data are consistent with an enhanced glycolysis and GABA shunt in response to a mild reduction in KGDHC. Our findings indicate that a mild change in KGDHC activity can lead to large changes in metabolism. The changes may maintain normal energy metabolism but make the cells more vulnerable to perturbations such as occur with oxidants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393030      PMCID: PMC2750872          DOI: 10.1111/j.1471-4159.2009.05955.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  Gamma hydroxybutyrate is not a GABA agonist.

Authors:  J J Feigenbaum; S G Howard
Journal:  Prog Neurobiol       Date:  1996-09       Impact factor: 11.685

2.  Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment.

Authors:  D S Albers; S J Augood; L C Park; S E Browne; D M Martin; J Adamson; M Hutton; D G Standaert; J P Vonsattel; G E Gibson; M F Beal
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

3.  Compartmentation of TCA cycle metabolism in cultured neocortical neurons revealed by 13C MR spectroscopy.

Authors:  H S Waagepetersen; U Sonnewald; O M Larsson; A Schousboe
Journal:  Neurochem Int       Date:  2000-04       Impact factor: 3.921

4.  Analysis of amino acids as their tert.-butyldimethylsilyl derivatives by gas-liquid chromatography and mass spectrometry.

Authors:  T P Mawhinney; R S Robinett; A Atalay; M A Madson
Journal:  J Chromatogr       Date:  1986-05-16

5.  An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.

Authors:  Y Mizuno; S Matuda; H Yoshino; H Mori; N Hattori; S Ikebe
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

6.  Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome.

Authors:  R F Butterworth; J J Kril; C G Harper
Journal:  Alcohol Clin Exp Res       Date:  1993-10       Impact factor: 3.455

7.  Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity.

Authors:  Peter Klivenyi; Anatoly A Starkov; Noel Y Calingasan; Gabrielle Gardian; Susan E Browne; Lichuan Yang; Parvesh Bubber; Gary E Gibson; Mulchand S Patel; M Flint Beal
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

8.  Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid.

Authors:  J W Geddes; J D Wood
Journal:  J Neurochem       Date:  1984-01       Impact factor: 5.372

9.  Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease.

Authors:  G E Gibson; K F Sheu; J P Blass; A Baker; K C Carlson; B Harding; P Perrino
Journal:  Arch Neurol       Date:  1988-08

10.  Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.

Authors:  F Mastrogiacomo; C Bergeron; S J Kish
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

View more
  12 in total

1.  Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.

Authors:  Gary E Gibson; Huan-Lian Chen; Hui Xu; Linghua Qiu; Zuoshang Xu; Travis T Denton; Qingli Shi
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

2.  Brain [U-13 C]glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity.

Authors:  Linn Hege Nilsen; Qingli Shi; Gary E Gibson; Ursula Sonnewald
Journal:  J Neurosci Res       Date:  2011-03-03       Impact factor: 4.164

3.  Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease.

Authors:  Kalpita Banerjee; Soumyabrata Munshi; Hui Xu; David E Frank; Huan-Lian Chen; Charleen T Chu; Jiwon Yang; Sunghee Cho; Valerian E Kagan; Travis T Denton; Yulia Y Tyurina; Jian Fei Jiang; Gary E Gibson
Journal:  Neurochem Int       Date:  2016-02-23       Impact factor: 3.921

4.  Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?

Authors:  Huanlian Chen; Travis T Denton; Hui Xu; Noel Calingasan; M Flint Beal; Gary E Gibson
Journal:  J Neurochem       Date:  2016-12       Impact factor: 5.372

5.  Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.

Authors:  P Bubber; V Hartounian; G E Gibson; J P Blass
Journal:  Eur Neuropsychopharmacol       Date:  2010-11-30       Impact factor: 4.600

6.  α-Ketoglutarate dehydrogenase complex moonlighting: ROS signalling added to the list: An Editorial highlight for 'Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?'

Authors:  Emilio Fernandez; Juan P Bolaños
Journal:  J Neurochem       Date:  2016-12       Impact factor: 5.372

Review 7.  Abnormal Glucose Metabolism in Alzheimer's Disease: Relation to Autophagy/Mitophagy and Therapeutic Approaches.

Authors:  Kalpita Banerjee; Soumyabrata Munshi; David E Frank; Gary E Gibson
Journal:  Neurochem Res       Date:  2015-06-16       Impact factor: 3.996

8.  The negative impact of α-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation.

Authors:  Gergely Kiss; Csaba Konrad; Judit Doczi; Anatoly A Starkov; Hibiki Kawamata; Giovanni Manfredi; Steven F Zhang; Gary E Gibson; M Flint Beal; Vera Adam-Vizi; Christos Chinopoulos
Journal:  FASEB J       Date:  2013-03-08       Impact factor: 5.191

Review 9.  Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.

Authors:  Gary E Gibson; Anatoly Starkov; John P Blass; Rajiv R Ratan; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2009-08-26

10.  Phosphonate analogs of 2-oxoglutarate perturb metabolism and gene expression in illuminated Arabidopsis leaves.

Authors:  Wagner L Araújo; Takayuki Tohge; Adriano Nunes-Nesi; Danilo M Daloso; Mhairi Nimick; Ina Krahnert; Victoria I Bunik; Greg B G Moorhead; Alisdair R Fernie
Journal:  Front Plant Sci       Date:  2012-06-04       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.